Current Drug Shortages: Which Medications Are Scarce Today in 2025
Dec, 28 2025
As of December 2025, over 270 drugs remain in short supply across the United States - a number that may seem smaller than last year’s peak, but still represents a dangerous level of instability in the healthcare system. Patients are missing treatments. Hospitals are rationing life-saving medications. And pharmacists are spending hours every week just trying to find replacements. This isn’t a temporary hiccup. These shortages are deep-rooted, systemic, and affecting real people right now.
What’s Actually in Short Supply?
The most critical shortages are happening in medications you might not expect to run out of - things like saline bags, IV fluids, and basic chemotherapy drugs. These aren’t luxury prescriptions. They’re the backbone of emergency care, cancer treatment, and daily hospital operations.- 5% Dextrose Injection (small volume bags) - Short since February 2022, expected to improve by August 2025. Used for hydration and delivering medications intravenously.
- 50% Dextrose Injection - Short since December 2021, resolution expected September 2025. Critical for treating severe low blood sugar in diabetics.
- Cisplatin - A key chemotherapy drug for testicular, ovarian, and lung cancers. A 2022 quality failure at an Indian manufacturing plant cut supply by half. Hospitals now prioritize patients with the highest survival benefit.
- Vancomycin - A last-resort antibiotic for serious infections. Shortages have forced doctors to delay treatments or use less effective alternatives.
- Levothyroxine - The most common thyroid hormone replacement. Demand has climbed 12% since 2023, and manufacturing delays have caused gaps in supply.
- GLP-1 agonists (e.g., semaglutide, tirzepatide) - Used for weight loss and type 2 diabetes. Demand has surged 35% annually since 2020. Pharmacies are limiting prescriptions to 30-day supplies.
- ADHD stimulants (e.g., methylphenidate, amphetamine salts) - Shortages have worsened as prescriptions increased by 28% in 2024 alone. Schools report students going without medication for weeks.
Why Do These Shortages Keep Happening?
It’s not one problem. It’s a chain reaction. Most generic drugs - which make up 90% of prescriptions - are made overseas. About 45% of active ingredients come from India, and 25% from China. These countries dominate production because they can make drugs cheaper. But that low cost comes with high risk. When a single facility in India fails an FDA inspection - like the one that stopped cisplatin production - it can wipe out half the U.S. supply. Quality issues, delayed inspections, and sudden export restrictions are common. Meanwhile, manufacturers have little incentive to fix problems. Generic drug profit margins are often just 5-8%. Compare that to brand-name drugs, which can earn 30-40%. Why would a company invest millions to upgrade equipment for a drug that sells for pennies? Demand spikes make things worse. When a new weight-loss drug becomes popular, demand can outpace production in months. No one planned for that surge. No one stockpiled extra. And when a hospital runs out of saline bags, they can’t just order more tomorrow. The supply chain moves slowly. It takes 12-18 months to build a new sterile IV line factory.
Who’s Getting Hurt?
It’s not abstract. It’s happening in hospitals, clinics, and homes. A 2024 AMA survey found that 78% of doctors had to delay treatments because of drug shortages. Nearly half said they had to switch patients to less effective or more toxic alternatives. In cancer care, 31% of patients experienced treatment delays averaging 14.7 days per interruption. That’s not just inconvenient - it can mean the difference between remission and progression. Pharmacists are drowning. According to ASHP, 92% spend more than 10 hours a week tracking down drugs. Many are forced to substitute medications without clear guidance. That leads to errors. One hospital in Ohio reported a 22% spike in medication errors during a cisplatin shortage because nurses were unfamiliar with the replacement drug’s dosing. Even simple things like IV fluids are causing crisis-level stress. Hospitals are turning to oral rehydration when possible. Nurses are diluting concentrated solutions. Parents are being told to give their sick kids more water instead of IV fluids. These aren’t ideal solutions. They’re desperate workarounds.What’s Being Done - And What’s Not
The FDA says it prevents about 200 potential shortages every year by stepping in early. But it can’t force a company to make more. It can’t require factories to upgrade. It can’t punish manufacturers who sit on stockpiles. In January 2025, the FDA launched a new portal where healthcare workers can report shortages not yet listed. In three months, it received over 1,200 reports - and acted on 87% of them. That’s progress. But it’s reactive, not preventative. Some states are trying. New York is building a public database to show which pharmacies still have shortage drugs. Hawaii is allowing Medicaid to use foreign-approved versions of drugs when U.S. versions aren’t available. These are smart, local fixes. But they don’t fix the national problem. The real solution needs three things:- Financial incentives - Tax breaks or subsidies for companies that make critical generic drugs in the U.S.
- Strategic stockpiles - Government-backed reserves of essential medications, like the national emergency oil reserve.
- Early warning system - A real-time network connecting manufacturers, distributors, and hospitals to predict shortages before they happen.
What You Can Do
If you’re a patient:- Ask your doctor or pharmacist: “Is my medication in short supply? Is there an alternative?”
- Don’t wait until your prescription runs out. Call ahead for refills - especially for chronic meds like thyroid or ADHD drugs.
- Keep a list of your medications and dosages. If you have to switch, you’ll need that info.
- Know the signs of medication withdrawal or ineffective treatment - confusion, fatigue, worsening symptoms.
- Reach out to patient advocacy groups like Patients for Affordable Drugs. They track shortages and can help connect you with resources.
- Report shortages to the FDA’s new portal - even if you think someone else already did.
- Follow your hospital’s shortage protocols. Don’t improvise unless it’s an emergency.
- Advocate for stockpiling. Push your admin to keep 30 days of critical drugs on hand.
Fabian Riewe
December 29, 2025 AT 08:42Been a pharmacist for 12 years, and this is the worst it’s ever been. I spent 4 hours yesterday just trying to find a single vial of 50% dextrose for a diabetic kid. No joke. We’re literally playing Russian roulette with basic meds now.
And don’t even get me started on how hospitals are diluting IV fluids. That’s not a workaround-it’s a gamble with someone’s life.
Lisa Dore
December 29, 2025 AT 18:27I’m a mom of a kid on levothyroxine, and we had to go 3 weeks without it last year. He got so lethargic, I thought he was depressed. Turned out his thyroid just crashed. We got lucky-our pharmacy had one last bottle tucked away.
But not everyone’s that lucky. We need stockpiles. Like, now. Not ‘let’s study it for another 6 months.’
Sharleen Luciano
December 31, 2025 AT 06:33Of course this is happening. We’ve outsourced everything to countries with zero regulatory oversight. Why would we expect anything else? The FDA is a paper tiger. They inspect factories once every five years and call it ‘due diligence.’
And now we’re surprised when the system collapses? Please. This is the inevitable result of 30 years of neoliberal decay. Wake up.
Jim Rice
January 1, 2026 AT 09:59Wait, so you’re saying we should pay more for generics? That’s just socialism. If people want their meds, they should’ve bought brand names. Or moved to Canada. Or just stopped being lazy and eating less sugar.
Also, why do we even need so many ADHD prescriptions? Kids these days can’t sit still because they’re on TikTok 24/7. Not because they’re ‘sick.’
Henriette Barrows
January 3, 2026 AT 01:01My uncle’s on cisplatin. He’s been on hold for chemo for 6 weeks now. He says he’s ‘fine,’ but I can tell-he’s scared. I didn’t even know this was happening until I saw this post.
It’s terrifying how invisible this is to most people. We think medicine is a given. It’s not. It’s a fragile thread.
Aliza Efraimov
January 4, 2026 AT 12:56Let me tell you what’s really happening behind the scenes. I work in a hospital pharmacy. We’re substituting carboplatin for cisplatin because it’s available. But carboplatin has a different toxicity profile. Nurses are getting confused. We’ve had two near-misses this month.
And the worst part? No one’s tracking these errors. No one’s reporting them. The system is designed to bury this stuff. We’re not just short on drugs-we’re short on accountability.
Nisha Marwaha
January 5, 2026 AT 14:04From India, I can confirm: the quality control crisis is real. Our facility that made cisplatin had a filtration system failure. FDA flagged it. We were shut down for 11 months. No one told the U.S. market. That’s how these shortages cascade.
But here’s the thing-we’re not the villains. We’re the backbone. We make 40% of the world’s generics. We’re underpaid, overworked, and constantly under inspection. The real issue? The profit model. No one invests in infrastructure when margins are 5%.
Paige Shipe
January 6, 2026 AT 13:48Drug shortages? More like drug entitlements. People think they deserve to be on semaglutide just because they’re overweight. And now we’re supposed to pay more so everyone can have their fancy weight loss pills? No.
My cousin got cancer. He didn’t get a miracle drug. He got chemo. And he died. Because the system was broken. So stop pretending this is about ‘patients.’ It’s about greed and laziness.
Tamar Dunlop
January 7, 2026 AT 18:33As a Canadian healthcare professional, I must say this situation is profoundly concerning. While we too face supply chain challenges, our national pharmacare framework ensures a baseline level of access, even during shortages.
It is imperative that the United States, as a global leader in medical innovation, does not allow market forces to dictate the availability of life-sustaining pharmaceuticals. This is not merely a logistical issue-it is a moral imperative.
David Chase
January 8, 2026 AT 01:20AMERICA FIRST!! 🇺🇸
Why are we letting INDIA AND CHINA control our MEDICINES?! We built the atomic bomb, we landed on the moon, and now we can’t make a saline bag?!
Bring back manufacturing! Tax the crap out of foreign drug makers! Ban imports until we make everything here! 🚨💊🇺🇸
Also, GLP-1 agonists? That’s just a fad. People need to eat less and move more. Stop blaming the system for your laziness.
Russell Thomas
January 9, 2026 AT 10:47Wow. So we’re supposed to feel bad because some rich guy can’t get his Ozempic? Meanwhile, my grandma’s on vancomycin and the hospital’s giving her a cheaper antibiotic that makes her vomit for 48 hours.
Guess what? The system doesn’t care about you. It cares about profit. And you’re all just screaming into the void while the CEOs laugh all the way to the bank.
Joe Kwon
January 10, 2026 AT 09:45Just wanted to add that the FDA’s new reporting portal is actually working better than people think. I reported a shortage of methylphenidate last month, and within 10 days, they contacted the manufacturer and got a shipment rerouted to my region.
It’s not perfect, but grassroots reporting + FDA action = real progress. We need more people using the portal, not just complaining.
Nicole K.
January 11, 2026 AT 09:06This is what happens when you let people get fat and lazy and then give them pills instead of telling them to go outside and walk. If you need ADHD meds, maybe you should stop scrolling on your phone for 12 hours a day.
And as for weight loss drugs? You don’t need semaglutide. You need willpower. And a mirror.
Amy Cannon
January 13, 2026 AT 08:43It is with profound gravity that I address the systemic failures in pharmaceutical supply chain governance, as elucidated in this most illuminating missive. The confluence of globalized manufacturing, insufficient regulatory reciprocity, and the commodification of essential therapeutics represents not merely a logistical deficit, but a civilizational failure of collective responsibility.
One must consider, for instance, the epistemological implications of relying upon geopolitical entities whose regulatory paradigms diverge significantly from those of the Western medical canon. Furthermore, the absence of a federally mandated strategic reserve-akin to the Strategic Petroleum Reserve-is not merely negligent, but tantamount to a dereliction of the social contract.
It is my earnest hope that legislative bodies, in their infinite wisdom, shall act with alacrity to institute a National Essential Medicines Reserve, funded by a modest levy on pharmaceutical conglomerates, and administered by a nonpartisan oversight committee. The cost of inaction, as we have witnessed, is measured not in dollars, but in human lives-each one irreplaceable, each one sacred.
Himanshu Singh
January 13, 2026 AT 16:44From India here. We make 70% of the world’s generic drugs, but we’re not getting credit. Factories are old, power cuts happen, and FDA inspections are scary. We want to fix it, but we need money and time.
Also, people in US think we just ‘make bad drugs.’ No. We make good drugs, but sometimes things go wrong. Please don’t hate us. We’re trying.